Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and trihexyphenidyl

3,4-dihydroxyphenylacetic acid has been researched along with trihexyphenidyl in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saitoh, T1
Ebinger, G; Izurieta-Sánchez, P; Michotte, Y; Sarre, S1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and trihexyphenidyl

ArticleYear
Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
    Journal of the neurological sciences, 1988, Volume: 83, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Clomipramine; Corpus Striatum; Dibenzocycloheptenes; Dopamine; Drug Interactions; Male; Mice; Mice, Inbred C57BL; Parasympatholytics; Parkinson Disease, Secondary; Pyridines; Pyrrolidines; Trihexyphenidyl

1988
Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats.
    European journal of pharmacology, 1998, Jul-17, Volume: 353, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Biotransformation; Corpus Striatum; Decarboxylation; Dopamine; Drug Interactions; Homovanillic Acid; Levodopa; Male; Microdialysis; Muscarinic Antagonists; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra; Trihexyphenidyl

1998